Emphasis on Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Others); Drug Type (Beta-Adrenergic Bronchodilators, Anticholinergic Bronchodilators, Phosphodiesterase Inhibitor, Combination Drugs, Others); Route of Administration (Oral, Injection, Inhaler) and Region/Country
Global Bronchodilators market is expected to register a CAGR of around ~5% over the period of 2021-2027. Bronchodilators are drugs that open up (dilate) the breathing passages by relaxing the bronchial smooth muscle. They make breathing easier for people with asthma or other lung conditions. Thus, the increase in the number of patients with respiratory disorders, and the treatment of various diseases such as asthma, chronic obstructive pulmonary disease, and others. The geriatric population is more vulnerable to respiratory disorders such as chronic obstructive pulmonary disease (COPD) and asthma. For instance, as per the data published by the Centers for Disease Control and Prevention (CDC), in 2019, around 4,069,278 Americans aged above 65 years were living with asthma. Since bronchodilators play a vital role in maintaining optimal airflow within the lungs of these patients, this is likely to boost the demand for bronchodilators in near future. Moreover, the development of advanced bronchodilators by major companies and the diagnostics industry owing to the presence of well-established market players and frequent product launches in the region. For instance, in July 2020, EVA Pharma launched ‘Inhalex’, the first Egyptian medication for COPD with a 24-hour lasting effect. This product launch is projected to reduce the cost of the treatment of COPD patients to half.
Abbott Laboratories, AstraZeneca plc., Boehringer Ingelheim International GmbH, GlaxoSmithKline Plc., F. Hoffmann-La Roche Ltd., Novartis AG., Pfizer Inc., SANOFI, Teva Pharmaceutical Industries Ltd., Vectura Group Plc are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst indication, asthma category is expected to witness the highest CAGR during the forecast period”
Based on indication, the market is categorized into asthma, chronic obstructive pulmonary disease (COPD), and others. Among these, asthma is expected to witness the highest CAGR during the forecast period owing to the rising prevalence of asthma worldwide. For instance, as per World Health Organization (WHO) data, asthma affected around 262 million people in 2019 and triggered 461,000 deaths worldwide. In addition, the increase in the prevalence of pulmonary disorders is increasing the growth of the bronchodilators market.
“Amongst the drug type, anticholinergics bronchodilators are expected to highest CAGR during the forecast period”
Based on drug type, the market is categorized into beta-adrenergic bronchodilators, anticholinergic bronchodilators, phosphodiesterase inhibitors, combination drugs, and others. Among these, the anticholinergic bronchodilators are expected to witness the highest CAGR during the forecast period as it is available in both long-acting and short-acting forms. Anticholinergics act by inhibiting the effect of acetylcholine on airways and nasal passages. It is widely used to treat chronic obstructive pulmonary disease. According to, institute for Health Metrics and Evaluation (IHME), Chronic respiratory diseases were responsible for 71.1 million YLLs and 32.4 million YLDs in 2019. Chronic obstructive pulmonary disease (COPD) and asthma were the two largest contributors to the global respiratory disease burden.
“North America to significant share during the forecast period”
North America accounted for a prominent share of the global bronchodilators market and is expected to grow at a significant growth rate during the forecast period owing to the quick adoption of bronchodilators technologies along with the high incidence of COPD and asthma cases. The United States Environmental Protection Agency and the National Health Interview Surveys (NHIS), in April 2021, estimated that almost 25.1 million people, comprising 5.1 million children, have asthma in the country. In addition, Major healthcare companies are investing heavily in their products due to rising social awareness among healthcare industry experts, medical professionals, and patients about the benefits that bronchodilators have to prompt the regulatory authorities to consider and authorize the bronchodilators.
Reasons to buy this report:
Customization Options:
Global Bronchodilators market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Global Bronchodilators Market Covid-19 Impact
6. Global Bronchodilators Market Revenue (usd Bn), 2019-2027f
7. Market Insights By Indication
8. Market Insights By Drug Type
9. Market Insights By Route Of Administration
10. Market Insights By Region
11. Bronchodilators Market Dynamics
12. Bronchodilators Market Opportunities
13. Bronchodilators Market Trends
14. Policy & Regulatory Framework
15. Demand And Supply-side Analysis
16. Value Chain Analysis
17. Competitive Scenario
18. Company Profiled
19. Disclaimer
Research Methodology for the Global Bronchodilators Market Analysis (2021-2027)
Analyzing the historical market, estimation of the current market, and forecasting the future market of the global bronchodilators market were the three major steps undertaken to create and analyze the adoption of bronchodilators in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global bronchodilators market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the bronchodilators market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Bronchodilators market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as an indication, drug type, route of administration, and region. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the bronchodilators market. Further, we conducted factor analysis using dependent and independent variables such as the indication, drug type, route of administration, and region of bronchodilators. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the bronchodilators market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Bronchodilators market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach were applied to arrive at the market forecast about 2027 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global bronchodilators market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of indication, drug type, route of administration, and region, and region in the global bronchodilators market.
The main objective of the Global Bronchodilators Market Study
The current & future market trends of the global bronchodilators market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
